24 Hour Work Effect on Physical and Psychoemotional Wellness of Internal Care Nurse

Baklaura darba tēma ir “Diennakts darba ietekme uz internās aprūpes māsas fizisko un psihoemocionālo pašsajūtu”. Darba mērķis - Noskaidrot diennkats darba ietekmi uz internās aprūpes māsas fizisko un psihoemocionālo pašsajūtu. Uzsākot darbu tiek izvirzīts pētījuma jautājums: “Kāda ir diennakts darba ietekme uz internās aprūpes māsas fizisko un psihoemocionālo pašsajūtu?”. Darba veikšanā izmantota kvalitatīvā pētījuma metode – intervijas. Pētījumā piedalījās 7 respondenti- Internās aprūpes māsas, kuras strādā diennakts dežūrās. Intervijas tika veiktas attālināti izmantojot e-pastu. Pētījuma rezultātā tiek sasniegts darba mērķis un sniegta atbilde uz pētījuma jautājumu. Māsas darba rezultātā izjūt tādus psihoemocionālos un fiziskos traucējumus, kā kāju un muguras sāpes, apetītes izmaiņas un nespēju koncentrēties. Bakalura darbs sastāv no teorētiskās un praktiskās daļas. Darba teorētiskajā daļā tiek apkopota informācija par pašsajūtas jēdzienu, fiziskās un psihoemocionālās pašsajūtas faktoriem un to radītajām sekām un internās aprūpes māsas darba specifiku.Bachelor work theme is “24 hour work effect on physical and psychoemotional wellness of internal care nurse”. Aim of the work- to find out effect on physical and psychoemotional wellness of 24 hour work of internal care nurse. At the beginning of the work, the question of the study is raised:What is the impact of 24 hours work on physical and psychoemotional wellness of an internal care nurse? The qualitative research method is used in work- interview. The study involved 7 respondents, internal care nurses who works 24 hours. Interviews were conducted remotely via email. The main aim of the work has been reached and the question of the research has been answered. As a result of her work, nurses feels psychoemotional and physical disorders such as leg and back pain, changes in appetite and inability to focus. Bachelor work consists of theoretical and practical parts. The theoretical part of the work summarises information on the concept of wellbeing, the factors of physical and psychoemotional wellbeing and the consequences thereof, and the specific of the work of the internal care nurse

Management tools for implementation and monitoring of requirements for enforcement of reducing sulphur oxides on ships: Latvia and Lithuania cases

The main type of bunker oil for ships is heavy fuel oil, derived as а residue from crude oil distillation. Crude oil contains sulphur which, following combustion in the engine, ends up in ship emissions. Sulphur oxides (SOx) are known to be harmful to human health, causing respiratory symptoms and lung diseases. Limiting SOx emissions from ships will improve air quality and protect the environment. From 1 January 2020, the limit for sulphur in fuel oil used on board ships operating outside designated emission control areas is reduced to 0,50% m/m. However, there are varying degrees of readiness among port and flag states for implementation and monitoring of requirements for enforcement of reducing Sulphur oxides on ships. In this paper are described management tools of states for implementing the inspection on Sulphur in ships fuel, analysed the states institutions activities for the enforcement of reducing Sulphur oxides on ships, and indicated the possibilities of increasing effectiveness of the management tools in Latvia and Lithuania

Rivaroxaban with or without aspirin in stable cardiovascular disease

BACKGROUND: We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention. METHODS: In this double-blind trial, we randomly assigned 27,395 participants with stable atherosclerotic vascular disease to receive rivaroxaban (2.5 mg twice daily) plus aspirin (100 mg once daily), rivaroxaban (5 mg twice daily), or aspirin (100 mg once daily). The primary outcome was a composite of cardiovascular death, stroke, or myocardial infarction. The study was stopped for superiority of the rivaroxaban-plus-aspirin group after a mean follow-up of 23 months. RESULTS: The primary outcome occurred in fewer patients in the rivaroxaban-plus-aspirin group than in the aspirin-alone group (379 patients [4.1%] vs. 496 patients [5.4%]; hazard ratio, 0.76; 95% confidence interval [CI], 0.66 to 0.86; P<0.001; z=−4.126), but major bleeding events occurred in more patients in the rivaroxaban-plus-aspirin group (288 patients [3.1%] vs. 170 patients [1.9%]; hazard ratio, 1.70; 95% CI, 1.40 to 2.05; P<0.001). There was no significant difference in intracranial or fatal bleeding between these two groups. There were 313 deaths (3.4%) in the rivaroxaban-plus-aspirin group as compared with 378 (4.1%) in the aspirin-alone group (hazard ratio, 0.82; 95% CI, 0.71 to 0.96; P=0.01; threshold P value for significance, 0.0025). The primary outcome did not occur in significantly fewer patients in the rivaroxaban-alone group than in the aspirin-alone group, but major bleeding events occurred in more patients in the rivaroxaban-alone group. CONCLUSIONS: Among patients with stable atherosclerotic vascular disease, those assigned to rivaroxaban (2.5 mg twice daily) plus aspirin had better cardiovascular outcomes and more major bleeding events than those assigned to aspirin alone. Rivaroxaban (5 mg twice daily) alone did not result in better cardiovascular outcomes than aspirin alone and resulted in more major bleeding events